Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, prompting calls for close monitoring in vulnerable individuals.

Key Points The largest healthcare stocks by market capitalization are undergoing significant sell-offs.This low-cost ETF ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...